Case–control study of endogenous sex steroid hormones and risk of endometrial cancer

[1]  G. Anderson,et al.  Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. , 2019, JNCI cancer spectrum.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  S. Harlow,et al.  Changes in androstenedione, dehydroepiandrosterone, testosterone, estradiol, and estrone over the menopausal transition , 2017, Women's Midlife Health.

[4]  L. Kuller,et al.  Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[5]  G. Hallmans,et al.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study , 2016, Hormones and Cancer.

[6]  W. Zheng,et al.  Insulin is an important risk factor of endometrial cancer among premenopausal women: a case-control study in China , 2016, Tumor Biology.

[7]  Xiaoxin Ma,et al.  Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies , 2015, Scientific Reports.

[8]  D. Greenwood,et al.  Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Hankinson,et al.  Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers , 2015, Steroids.

[10]  A. Talhouk,et al.  Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors. , 2015, Gynecologic oncology.

[11]  Richard Stevens,et al.  Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. , 2015, The Lancet. Oncology.

[12]  D. Brenner.  Cancer incidence due to excess body weight and leisure-time physical inactivity in Canada: implications for prevention. , 2014, Preventive medicine.

[13]  E. Giovannucci,et al.  Leisure‐time physical activity and endometrial cancer risk: Dose–response meta‐analysis of epidemiological studies , 2014, International journal of cancer.

[14]  K. Garg,et al.  Endometrial carcinoma in women aged 40 years and younger. , 2014, Archives of pathology & laboratory medicine.

[15]  C. Friedenreich,et al.  Hormone Contraception before the First Birth and Endometrial Cancer Risk , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[16]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Ries,et al.  Trends in Endometrial Cancer Incidence by Race and Histology with a Correction for the Prevalence of Hysterectomy, SEER 1992 to 2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[18]  S. Mayne,et al.  Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancer , 2012 .

[19]  C. Friedenreich,et al.  Case–Control Study of the Metabolic Syndrome and Metabolic Risk Factors for Endometrial Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[20]  I. Lambrinoudaki,et al.  Sex Hormones in Postmenopausal Women Receiving Low‐Dose Hormone Therapy: The Effect of BMI , 2011, Obesity.

[21]  C. Guillemette,et al.  Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. , 2011, The Journal of clinical endocrinology and metabolism.

[22]  F. Clavel-Chapelon,et al.  Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition , 2010, International journal of cancer.

[23]  C. Friedenreich,et al.  Case–control study of lifetime total physical activity and endometrial cancer risk , 2010, Cancer Causes & Control.

[24]  S. Pauklin,et al.  Estrogen directly activates AID transcription and function , 2009, The Journal of experimental medicine.

[25]  J. Chang-Claude,et al.  Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2008, Endocrine-related cancer.

[26]  J. Manson,et al.  A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[27]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[28]  D. Voskuil,et al.  Physical Activity and Endometrial Cancer Risk, a Systematic Review of Current Evidence , 2007, Cancer Epidemiology Biomarkers & Prevention.

[29]  A. Berchuck,et al.  Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. , 2006, Gynecologic oncology.

[30]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[31]  F. Berrino,et al.  Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women , 2004, International journal of cancer.

[32]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[33]  R. Shore,et al.  Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study , 2001, British Journal of Cancer.

[34]  E. Barrett-Connor,et al.  Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. , 2000, The Journal of clinical endocrinology and metabolism.

[35]  D. Hosmer,et al.  A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.

[36]  R. Hoover,et al.  Case-control study of endogenous steroid hormones and endometrial cancer. , 1996, Journal of the National Cancer Institute.

[37]  J. Manson,et al.  Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  C. Hagen,et al.  Plasma oestrogens in postmenopausal women with endometrial cancer , 1993, British journal of obstetrics and gynaecology.

[39]  N. Einhorn†,et al.  Is there an altered steroid profile in patients with endometrial carcinoma? , 1993, Cancer.

[40]  K. Hatch,et al.  Endometrial cancer, obesity, and body fat distribution. , 1991, Cancer research.

[41]  W. Cleveland,et al.  Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .

[42]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[43]  R. Bergström,et al.  Serum estrogens and androgens in women with endometrial carcinoma. , 1986, Gynecologic oncology.

[44]  M. Anderson,et al.  The relationship between oestradiol metabolism and adrenal steroids in the endometrium of postmenopausal women with and without endometrial cancer. , 1986, European journal of cancer & clinical oncology.

[45]  E. Hannigan,et al.  Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. , 1986, The Journal of clinical endocrinology and metabolism.

[46]  G. Siklósi,et al.  Endocrine factors in the etiology of endometrial carcinoma. , 1986, Neoplasma.

[47]  G. Bolelli,et al.  Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer , 1984, Cancer.

[48]  M. Sharf,et al.  Hormonal profile of endometrial cancer. , 1984, Gynecologic and obstetric investigation.

[49]  L. Falsetti,et al.  Profiles and endocrine correlations in endometrial carcinoma. , 1983, European journal of gynaecological oncology.

[50]  B. Claustrat,et al.  Estradiol, androstenedione, testosterone, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer. , 1982, Gynecologic oncology.

[51]  P. Scirpa,et al.  Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. , 1982, Maturitas.

[52]  B. Runnebaum,et al.  Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma. , 1981, Maturitas.

[53]  B. J. Davidson,et al.  Free estradiol in postmenopausal women with and without endometrial cancer. , 1981, The Journal of clinical endocrinology and metabolism.

[54]  B. J. Davidson,et al.  Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. , 1980, American journal of obstetrics and gynecology.

[55]  B. J. Davidson,et al.  Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. , 1980, American journal of obstetrics and gynecology.

[56]  K. Carlström,et al.  Serum Levels of Total Dehydroepiandrosterone and Total Estrone in Postmenopausal Women with Special Regard to Carcinoma of the Uterine Corpus , 1979, Acta obstetricia et gynecologica Scandinavica.

[57]  P. Siiteri.  Steroid hormones and endometrial cancer. , 1978, Cancer research.

[58]  F. Benjamin,et al.  Plasma levels of fractionated estrogens and pituitary hormones in endometrial carcinoma. , 1976, American journal of obstetrics and gynecology.

[59]  S. Romney,et al.  Plasma estrogen in patients with endometrial hyperplasia and carcinoma , 1976, Cancer.

[60]  S. Yen,et al.  Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. , 1976, The Journal of clinical endocrinology and metabolism.